Listen to Milena Izmirlieva from our Life Sciences team talk about bed shortages. https://t.co/epnfyXGUMH
Optimize and protect your pharmaceutical pricing
The International Reference Pricing Strategic Guidebook: 2019 Edition provides an in-depth look at the ripple effect of IRP and offers ways to optimize and protect pharmaceutical pricing in this complex global environment.DOWNLOAD SAMPLE
Alzheimer's and dementia treatment a USD1 trillion market
With the cost of Alzheimer's and dementia treatment predicted to reach USD1 trillion by 2018, we examine the latest R&D trends and prospects in this therapeutic area.DOWNLOAD NOW
Impact of Brexit on Healthcare
Daily political developments on Brexit in the United Kingdom have led pharmaceutical companies to reassess the likelihood that the United Kingdom is heading. We look at three possible scenariosDOWNLOAD NOW
Who we are
An independent and holistic view of global healthcare and pharmaceutical markets
We offer comprehensive and independent coverage of pricing and reimbursement developments, processes and market trends alongside award-winning economic data and analysis, enabling our customers to optimize market access and revenue.
With unique data, analytics and tools produced by our team of experts, we help you monitor and quantify the global impact of the competitive pricing and reimbursement environment, market access and tendering strategies, disease trends and therapeutic breakthroughs, evolving healthcare budget and expenditures, healthcare workforce needs and much more.
Contact UsView global sales phone numbers
Life Sciences Products & Solutions
Pricing & Reimbursement
Engineering Intelligence for Medical Devices
Not sure what product you need?
Blogs & AnalysisView All
UK bans parallel export of two COVID-19 treatment candidates to protect national supply